New Drug Entresto for Heart Failure Drums Up a Lot of Enthusiasm
Finally, Attention Switches To Progressive Multiple Sclerosis
CMS Takes the Lead In Oncology Payment Reform
Randy Vogenberg, PhD: The differences among the latest diabetes medications are seen as less than dramatic, creating questions about the costs and benefits of the various new treatment options. Meanwhile, patient compliance remains a concern.